|Bid||1.4700 x 1300|
|Ask||1.5900 x 800|
|Day's Range||1.4400 - 1.5755|
|52 Week Range||1.1900 - 36.0000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 18, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Many of the most successful online businesses rely on experimentation to stay on top. San Francisco startup Eppo wants to help all companies run and manage such tests.
Airbnb's $10 million initiative is a response to travelers' cravings for unique destination rentals.
BERWYN, Pa., May 19, 2022--Virpax® Pharmaceuticals, Inc. ("Virpax") (NASDAQ: VRPX), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Tuesday, May 24th starting at 7:00 a.m. ET through Friday, May 27th. Anthony P. Mack, Chairman & CEO of Virpax, will be giving the presentation. Management will also be hosting virtual one-on-one meetings on Wedn